[go: up one dir, main page]

SI2686013T1 - Zdravljenje alergije na arašide - Google Patents

Zdravljenje alergije na arašide

Info

Publication number
SI2686013T1
SI2686013T1 SI201231014T SI201231014T SI2686013T1 SI 2686013 T1 SI2686013 T1 SI 2686013T1 SI 201231014 T SI201231014 T SI 201231014T SI 201231014 T SI201231014 T SI 201231014T SI 2686013 T1 SI2686013 T1 SI 2686013T1
Authority
SI
Slovenia
Prior art keywords
treatment
peanut allergy
allergy
peanut
Prior art date
Application number
SI201231014T
Other languages
English (en)
Inventor
Andrew Clark
Pamela Ewan
Original Assignee
Cambridge University Hospitals Nhs Foundation Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Hospitals Nhs Foundation Trust filed Critical Cambridge University Hospitals Nhs Foundation Trust
Publication of SI2686013T1 publication Critical patent/SI2686013T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
SI201231014T 2011-03-17 2012-03-16 Zdravljenje alergije na arašide SI2686013T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1104537.4A GB201104537D0 (en) 2011-03-17 2011-03-17 Treatment for peanut allergy
PCT/GB2012/050584 WO2012123759A1 (en) 2011-03-17 2012-03-16 Treatment for peanut allergy
EP12712344.6A EP2686013B1 (en) 2011-03-17 2012-03-16 Treatment for peanut allergy

Publications (1)

Publication Number Publication Date
SI2686013T1 true SI2686013T1 (sl) 2017-10-30

Family

ID=44012746

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201231014T SI2686013T1 (sl) 2011-03-17 2012-03-16 Zdravljenje alergije na arašide

Country Status (20)

Country Link
US (1) US9481716B2 (sl)
EP (1) EP2686013B1 (sl)
JP (1) JP2014509606A (sl)
CN (1) CN103596589A (sl)
AU (1) AU2012228033B2 (sl)
CA (1) CA2867529C (sl)
CY (1) CY1119074T1 (sl)
DK (1) DK2686013T3 (sl)
ES (1) ES2633319T3 (sl)
GB (1) GB201104537D0 (sl)
HR (1) HRP20170868T1 (sl)
HU (1) HUE035385T2 (sl)
LT (1) LT2686013T (sl)
PL (1) PL2686013T3 (sl)
PT (1) PT2686013T (sl)
RS (1) RS56043B1 (sl)
SG (2) SG10201602013SA (sl)
SI (1) SI2686013T1 (sl)
SM (1) SMT201700384T1 (sl)
WO (1) WO2012123759A1 (sl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110075285A (zh) * 2012-10-30 2019-08-02 阿拉沃克斯有限公司 新颖的免疫治疗分子和其用途
ES2940686T3 (es) * 2013-03-14 2023-05-10 Nestle Sa Fabricación de formulaciones de cacahuete para la desensibilización oral
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
HK1219436A1 (zh) * 2013-03-15 2017-04-07 Sementis Limited 免疫调节
WO2015187736A1 (en) * 2014-06-02 2015-12-10 Allergen Research Corporation Placebo formulations and uses thereof
CN106535931A (zh) 2014-08-25 2017-03-22 艾慕恩治疗公司 卵蛋白制剂及其制备方法
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
JP6859261B2 (ja) 2015-02-20 2021-04-14 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ 混合アレルゲン組成物およびそれを使用する方法
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
WO2016138030A2 (en) * 2015-02-23 2016-09-01 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
US10856567B2 (en) * 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
CA3069967A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. Methods for making mixed allergen compositions
US10603376B2 (en) 2017-08-30 2020-03-31 Roberto Garcia-Ibanez Immunotherapy for the treatment of allergic disease
MX2020004683A (es) 2017-11-02 2020-08-13 Aimmune Therapeutics Inc Metodos de inmunoterapia oral.
GB201718342D0 (en) 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
ES2997871T3 (en) * 2017-12-06 2025-02-18 Prollergy Corp Composition and method for reducing allergic response
WO2019142189A1 (en) * 2018-01-16 2019-07-25 Tel Hashomer Medical Research Infrastructure And Services Ltd. Treatment and prevention of seed allergies
US20190359660A1 (en) * 2018-05-22 2019-11-28 AllerGenis LLC Peptides And Methods For Detecting Peanut Allergies
JP7319351B2 (ja) 2018-07-27 2023-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法の単位用量分配システムおよび方法
WO2020037151A1 (en) * 2018-08-16 2020-02-20 Aimmune Therapeutics, Inc. Peanut oral immunotherapy with maintenance dose
WO2020100024A1 (en) * 2018-11-12 2020-05-22 Murdoch Childrens Research Institute Method and system
US12226448B2 (en) 2018-12-20 2025-02-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
KR20210130147A (ko) 2019-01-23 2021-10-29 비포어 브랜즈, 인크. 혼합 알레르겐 조성물의 제조 방법
AU2020247806A1 (en) * 2019-03-22 2021-10-07 Société des Produits Nestlé S.A. Systemic allergic response risk assessment in peanut oral immunotherapy
AU2020276213A1 (en) 2019-05-10 2021-10-28 Société des Produits Nestlé S.A. Methods for improving the quality of life of a patient with a peanut allergy
WO2020237181A1 (en) * 2019-05-23 2020-11-26 Aimmune Therapeutics, Inc. Methods of treating peanut allergy by oral immunotherapy with low-dose maintenance
US20210151155A1 (en) * 2019-11-20 2021-05-20 Aimmune Therapeutics, Inc. Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
AU2020412960A1 (en) * 2019-12-23 2022-06-16 Prota Therapeutics Pty Ltd Allergy treatment
JP2023506028A (ja) * 2019-12-23 2023-02-14 プロタ セラピューティクス ピーティワイ リミテッド 医薬組成物
WO2023200316A1 (ko) * 2022-04-15 2023-10-19 사회복지법인 삼성생명공익재단 경구면역요법을 이용한 식품알레르기 치료서비스 제공방법, 이를 구현하기 위한 기록매체에 저장된 컴퓨터 프로그램 및 시스템
NL2033338B1 (en) 2022-10-17 2024-05-03 Vini Mini B V Prevention of tree nut and seed allergy in humans
WO2025080707A1 (en) * 2023-10-10 2025-04-17 Intrommune Therapeutics, Inc. Methods of inducing tolerance and reducing adverse reactions to one or more food allergens
WO2025109005A1 (en) * 2023-11-20 2025-05-30 Cambridge Allergy Ltd. Immunotherapy for treatment of allergy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product

Also Published As

Publication number Publication date
SMT201700384T1 (it) 2017-09-07
JP2014509606A (ja) 2014-04-21
EP2686013A1 (en) 2014-01-22
US9481716B2 (en) 2016-11-01
DK2686013T3 (en) 2017-07-10
SG10201602013SA (en) 2016-04-28
AU2012228033A1 (en) 2013-10-31
PL2686013T3 (pl) 2017-10-31
LT2686013T (lt) 2017-07-10
CN103596589A (zh) 2014-02-19
CY1119074T1 (el) 2018-01-10
HUE035385T2 (en) 2018-05-02
US20140093541A1 (en) 2014-04-03
GB201104537D0 (en) 2011-05-04
CA2867529C (en) 2022-08-23
HRP20170868T1 (hr) 2017-08-25
SG193518A1 (en) 2013-10-30
ES2633319T3 (es) 2017-09-20
EP2686013B1 (en) 2017-05-03
CA2867529A1 (en) 2012-09-20
AU2012228033B2 (en) 2016-09-15
WO2012123759A1 (en) 2012-09-20
RS56043B1 (sr) 2017-09-29
PT2686013T (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
SG10201602013SA (en) Treatment for peanut allergy
IL227636A0 (en) Multimetric filtering
BR112013022820A2 (pt) método de tratamento
GB201119774D0 (en) IBS treatment
ZA201308117B (en) Avian-based treatment
GB201105523D0 (en) Treatment method
GB201121950D0 (en) Treatment process
GB201119171D0 (en) Gas treatment
GB201102283D0 (en) Treatment
GB2489207B (en) Waste treatment
GB201102284D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102282D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201102266D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201102268D0 (en) Treatment
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102273D0 (en) Treatment